BC Platforms

What BC Platforms does

BC Platforms AG is a Zürich-headquartered, privately-held data and technology company founded in 1997 that builds software and curated real-world data infrastructure for personalized and precision medicine. Its modular platform centers on BC Unify, an AI-driven data mastering engine that ingests, harmonizes, transforms and enriches multi-modal data (clinical, EMR, eCRF, lab, multi-omics and imaging); BC Mosaic, an EHDS-ready Trusted Research Environment deployed on AWS with native NVIDIA GPU acceleration and Flower Labs federated learning; BC Catalyst, a proprietary agentic AI analytics layer exposing prompt-based queries over harmonized genomic and RWD; BC Image, an AI-driven medical image de-identification and processing module; and BC Data, a global real-world data network aggregating 187M+ patient lives across 35+ countries via 150+ data partners.

The company sells primarily through enterprise contracts and subscriptions to top-20 pharmaceutical companies and 150+ healthcare organizations (university hospitals, biobanks, research institutions), with BC Mosaic also listed on AWS Marketplace for pay-as-you-go procurement. Revenue is generated via recurring enterprise subscriptions for BC Mosaic, BC Unify, BC Image and BC Data, BC Catalyst subscription analytics, professional services led by the Global Head of Technology and Data Services, and revenue-sharing arrangements with hospitals that commercialize anonymized datasets through the global data partner network. Distribution combines direct enterprise field sales with regional leadership (e.g., SVP APAC & Japan), hyperscaler co-selling (AWS, NVIDIA), and consortium participation (TEHDAS2, EHDS2 reference architecture with Modirum Platforms, VEIL.AI, Productivity Leap).

Name

BC Platforms

Legal name

BC Platforms AG

Website

https://bcplatforms.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

101–250 employees

Short description

BC Platforms is a Swiss-headquartered data and technology company that builds AI-powered trusted research environments, data mastering, and analytics software for top-20 pharmaceutical companies and 150+ healthcare organizations, backed by a global real-world data network covering 187M+ patient lives across 35+ countries.

Ownership category

akta.pro rank

Product category

Healthcare Real-World Data & Precision Medicine Analytics

NAICS

Scientific Research and Development Services (5417), Software Publishers (5132)

SIC

Laboratory Analytical Instruments (3826)

akta.pro primary industry

Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)

akta.pro secondary industries

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening) (HLAAAIAE), Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF)

Keywords

• Real-world data analytics
• Trusted research environments
• Precision medicine platforms
• Clinical data harmonization
• Federated data infrastructure

Headquarters

HQ city

Zürich

HQ country

Switzerland

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

1. BC Catalyst Subscription: BC Catalyst is offered by subscription to pharmaceutical, biotech and medtech organizations; pricing model is described as 'Available by subscription' leveraging the proprietary agentic AI platform.
2. BC Mosaic, BC Unify, BC Image and BC Data Enterprise Subscriptions: Recurring enterprise contracts for the BC Mosaic trusted research environment (available on AWS Marketplace), BC Unify data mastering platform, BC Image medical image processing platform, and BC Data global real-world data network serving life sciences and healthcare customers.
3. Scientific & Technology Consulting Services: Expert guidance for evidence generation, data integration, scalable analytics and AI, led by Narasimha Kumar (Global Head of Technology and Data Services); delivery of consulting across technology, data, and regulated environments.
4. Healthcare Data Monetization via Global Data Partner Network: Revenue-sharing programs with healthcare institutions joining the global data partner network ('anonymize, monetize, and safely store your treatment data… share in revenue-based projects'), enabling hospitals to commercialize anonymized datasets.

Pricing tiers

Go-to-market motion5 records

Distribution channels6 records

Marketing channels8 records

Core offering

BC Platforms provides a modular AI-driven platform (BC Unify, BC Catalyst, BC Mosaic, BC Image) for ingesting, harmonizing and analyzing clinical, genomic, multi-omics and imaging real-world data, supported by a global network of 150+ data partners covering 187M+ patient lives across 35+ countries. The offering targets life sciences companies and healthcare institutions with EHDS-ready Trusted Research Environments, federated analytics and AI-native precision medicine tools across the drug development lifecycle, complemented by Scientific & Technology Consulting services.

Product overview

BC Platforms offers a modular, AI-driven platform-plus-modules architecture for global healthcare data management and analytics across the drug development lifecycle. The core data mastering platform BC Unify ingests, harmonizes, and enriches multi-modal research-ready data; BC Mosaic is the AI-powered Trusted Research Environment (TRE) where compliant analysis, federated learning (via Flower Labs), and NVIDIA-accelerated computing are deployed; BC Catalyst is the proprietary agentic AI analytics layer that consumes BC Unify data via prompt-based queries; BC Image is the computer-vision module for medical imaging; and BC Data is the underlying global real-world data network of 150+ partners covering 187M+ patient lives across 35+ countries. Scientific & Technology Consulting wraps the platform with expert services, while acquired brands 4Pharma and Medexprim extend clinical trial and clinical-imaging real-world data capabilities.

Differentiator

Problem solved

Functional benefit

Brands

• BC Unify: AI-driven, end-to-end data mastering platform that ingests, harmonizes, transforms, and enriches multi-modal data to power other BC Platforms solutions.
• BC Catalyst
• BC Image
• BC Mosaic
• BC Data

Products and services

• BC Unify End-to-end AI-driven data mastering platform that ingests, harmonizes, transforms and enriches clinical, EMR, eCRF, lab, multi-omics and imaging data into research-ready datasets; powers downstream BC Catalyst and BC Mosaic analytics for life sciences and healthcare customers.
• BC Catalyst First-to-market AI-native analytics platform using a proprietary agentic AI model and prompt-based natural language interface to transform genomic and real-world clinical data into actionable insights across the full drug lifecycle — cohort identification, biomarker discovery, drug target identification, genetic variant interpretation and standards-of-care analysis. Available by subscription to pharma, biotech and medtech organizations.
• BC Mosaic Next-generation AI-powered Trusted Research Environment (TRE) for clinical, genomic and multi-omics studies. Listed on AWS Marketplace; integrates NVIDIA GPU acceleration and Flower Labs federated machine learning; provides multi-tier role-based access, federated research, audit trails and significantly reduced deployment times for healthcare and life sciences customers preparing for EHDS.
• BC Image AI-driven, end-to-end platform that automates extraction, de-identification, processing and contextual augmentation of medical images (X-Rays, MRIs, CT scans). Powered by NVIDIA CUDA; deployed across European hospitals to de-identify and harmonize millions of images per week while remaining GDPR compliant.
• BC Data Global real-world data network providing curated clinical, EMR, eCRF, lab, multi-omics and imaging datasets across oncology, neurology, rare diseases, immunology and other therapeutic areas. Accessed through 150+ global data partners and covering 187M+ patient lives across 35+ countries, with >90% of patients outside the US.
• Scientific & Technology Consulting Expert consulting services covering evidence generation, data integration, scalable analytics and AI strategy for life sciences and healthcare clients. Delivered globally under the Technology Consulting practice led by Narasimha Kumar, Global Head of Technology and Data Services.
• EHDS-Ready Trusted Research Environment Hardware-agnostic, EHDS-ready Trusted Research Environment for EU healthcare institutions needing to comply with European Health Data Space regulations. Supports OMOP CDM, FHIR and openEHR standards, federated analysis and AI-based tools across local and national secure data environments.

Quantifiable outcome

• Up to 80x faster AI-driven analytics across multi-modal health data versus traditional CPU-only processing
• +5 more outcomes

Named customers19 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration10 records

AI capability11 records

Feature8 records

Partnerships

20 partnerships are on record, tiered core, flagship and minor.

• Flower LabscoreTechnology or Integration · 9 June 2026BC Platforms partnered with Flower Labs to integrate the Flower SuperGrid and Flower Framework inside BC Mosaic TRE, enabling federated machine learning across distributed clinical, real-world and multi-modal data without moving sensitive data. Each organization can deploy a Flower SuperNode within its environment while SuperGrid coordinates workflows across participating sites, supporting EHDS-compliant multi-institutional AI development.
• AWS MarketplacecoreOEM/ Whitelabel/ Licensing Partner · 8 May 2026BC Mosaic trusted research environment is published on AWS Marketplace, allowing AWS customers to procure and deploy BC Mosaic through the marketplace as part of the AWS Strategic Collaboration Agreement.
• Amazon Web Services (AWS)flagshipStrategic or Co-development Partner · 4 May 2026BC Platforms signed a Strategic Collaboration Agreement (SCA) with AWS to enhance the BC Mosaic trusted research environment, scale secure AI-powered research environments, and prepare customers for the European Health Data Space (EHDS). The collaboration includes joint go-to-market initiatives, AWS Marketplace availability of BC Mosaic, co-selling activities, and the use of AWS Bedrock, SageMaker and other ML/AI services within BC Mosaic. BC Mosaic runs natively on AWS cloud infrastructure and supports genomic and clinical datasets from 187M+ patient lives across 35+ countries.
• NVIDIAflagshipTechnology or Integration · 5 March 2026NVIDIA technologies are natively integrated into BC Mosaic and BC Image. The integration delivers out-of-the-box access to NVIDIA GPUs, NVIDIA Rapids, cuDF, cuGraph, NetworkX and CUDA within the BC Mosaic trusted research environment, enabling up to 80x faster AI-driven analytics across multi-modal datasets (e.g., cuDF vs. pandas benchmarks on T4 GPUs / AWS EC2 G4 instances). BC Image already uses NVIDIA CUDA for high-volume medical image de-identification and processing.
• OmicsBankcoreStrategic or Co-development Partner · 6 February 2026Strategic partnership to expand access to large-scale real-world and multi-omics datasets from India (~12 million patients) and the UAE (~500,000 patients), with plans for further expansion into Saudi Arabia, Taiwan, the Philippines and Malaysia. The collaboration addresses the under-representation of South Asian populations (<2%) in global genome-wide association studies and brings BC Platforms' global patient catchment to over 187 million patient lives across 35+ countries.
• GeneVault LifesciencescoreStrategic or Co-development Partner · 18 December 2025Strategic partnership integrating GeneVault's network of over 115 medical facilities and 120 hospitals in Asia, the Middle East, Africa and Latin America into BC Platforms' BC Unify data mastering platform. Adds 48 million patient lives across 13 countries, expanding BC Platforms' global data partner network to 175M+ patient lives across 35+ countries, spanning oncology, immunology, neurology, cardiology and rare diseases.
• National Health Research Institutes (NHRI) TaiwancoreStrategic or Co-development Partner · 3 December 2025Co-development partnership for the HARBOR Trusted Research Environment using the UK Five Safes model (Safe People, Safe Projects, Safe Settings, Safe Data, Safe Output); enables compliant and secure research at scale. NHRI is exploring cross-border collaborations including with Singapore's A*STAR.
• Yonsei University Health SystemminorStrategic or Co-development Partner · 3 December 2025Co-organized Smart Healthcare International Symposium with AWS and BC Platforms; Yonsei presented its hybrid-cloud data lake architecture (Y-KNOT bilingual LLM) linking on-premise data lakes to AWS via VPN for clinical workflows.
• Academia Sinica and Asia University (Taiwan)minorStrategic or Co-development Partner · 3 December 2025AWS is collaborating with Academia Sinica and Asia University to support the Healthy Taiwan initiative within the new AWS Asia Pacific (Taipei) Region; BC Platforms participates as a key data partner in the forum.
• NTT entities (Japan Precision Medicine Platform)coreStrategic or Co-development Partner · 1 April 2024BC Platforms AG collaboration with NTT entities on the Japan Precision Medicine Platform (April 2024), cited as a key recent development in the precision medicine software market.
• Modirum PlatformscoreStrategic or Co-development Partner · 1 January 2024Co-development partner for the EHDS2 reference architecture. Modirum Platforms provides software for Health Data Access Bodies and Trusted Data Holders (often university hospitals) to automate EHDS2-compliant data request and data access approval processes, including cybersecurity controls.
• VEIL.AIcoreStrategic or Co-development Partner · 1 January 2024Co-development partner for the EHDS2 reference architecture. VEIL.AI provides next-generation AI-enhanced anonymization and synthetization technology that preserves critical data relationships in anonymized datasets, ensuring EHDS-compliant data release.
• Productivity LeapcoreImplementation/ SI/ Consulting Partner · 1 January 2024Finnish IT consulting company (part of Digia Group) and EHDEN-certified SME partner; provides EHR data mapping to OMOP CDM, harmonization services and integration projects that feed the EHDS2 reference architecture pipeline.
• MedexprimcoreStrategic or Co-development Partner · 1 December 2023BC Platforms acquired Medexprim, a French real-world data company, expanding its ability to offer clinical and imaging data across Europe. Deal terms were undisclosed; the acquisition follows the earlier acquisition of 4Pharma and is cited as creating the world's largest health data network focused on precision medicine and real-world evidence analytics.
• 4PharmacoreStrategic or Co-development Partner · 1 June 2023BC Platforms acquired 4Pharma, a provider of medical research data and services, expanding its global clinical trial and real-world data capabilities and enhancing its service portfolio in healthcare data management and analytics, with an emphasis on precision medicine and data privacy.
• Helsinki University Hospital (HUS) and Findata ecosystemcoreImplementation/ SI/ Consulting PartnerBC Platforms' software is deployed in Finnish health data research environments, including HUS which receives ~800 data requests annually (~95% internal) leading to ~200 projects with granted data access. The platform automates Data Discovery, Data Access Application Management, Data Release and Secure Processing Environment for federated analyses; Finland is the first country to have secondary and biobank laws and an official Health Data Access Body (HDAB).
• HDR UK (Health Data Research UK) and 11 NHS TrustscoreStrategic or Co-development PartnerBC Platforms' software is used to implement the HDR-UK real-time data availability query service that combines 11 NHS Trusts in one federated platform, providing a benchmark for EHDS-style deployment.
• TEHDAS2 consortium (EU)flagshipStrategic or Co-development PartnerBC Platforms is part of the TEHDAS2 stakeholder forum developing universal guidelines and technical specifications for the secondary use of health data under EHDS, contributing via its R&D center in Espoo, Finland.
• University of British Columbia, University of Nottingham, Imperial College Healthcare NHS Trust, NHS University Hospital Southampton, Medical University of Graz Biobank, University of Tartu Estonian Genome Center, UniKlinikum Wurzburg, Institut Gustave Roussy, Centre Antoine Lacassagne, Centre Leon Berard, Hopital Foch, Hopital Saint-Joseph Marseille, OncoValue, IDx Lung, Helios Health (Singapore), Technology Industries of FinlandminorOthersFeatured customer logos on bcplatforms.com representing the global data partner network across university hospitals, biobanks, research institutions and industry partners feeding the BC Unify data mastering platform.
• A*STAR SingaporeminorStrategic or Co-development PartnerCross-border research discussions between NHRI Taiwan and Singapore's A*STAR for the HARBOR TRE platform; BC Platforms participates as data partner in the regional ecosystem.

Scale indicators11 records

Recent moves6 records

Expansion highlights7 records

Emerging players

• Owkin: Owkin combines federated AI and real-world patient data for pharma and academic research, overlapping with BC Platforms' federated learning and EHDS-style use cases from a more AI-first angle.

Direct peers

• TriNetX: TriNetX operates a global federated health research network used by top pharmas for trial feasibility, real-world evidence and cohort queries, directly competing with BC Data and BC Catalyst.
• Velsera (formerly Seven Bridges): Velsera provides a biomedical informatics platform for genomics, transcriptomics and clinical research, with federated and TRE capabilities directly comparable to BC Platforms' offerings.
• Datavant: Datavant focuses on privacy-preserving linking and exchange of real-world health data, closely related to BC Platforms' data mastering, de-identification and federated research capabilities.
• Lifebit: Lifebit builds federated genomics and biomedical data platforms with Trusted Research Environments, positioning it as a direct competitor to BC Mosaic in pharma and population genomics.
• DNAnexus: DNAnexus operates a cloud-based biomedical data analysis and collaboration platform for genomics and clinical research, directly competing with BC Mosaic TRE and BC Unify in the federated genomics/RWE category.

Broad incumbents

• IQVIA (E360 / Orchestrated Patient Cloud): IQVIA is a deep incumbent in clinical research and real-world evidence with a federated data network; an existing BC Platforms investor (2019 round) and a broad incumbent competing for similar pharma RWD and analytics budgets.
• Tempus Labs: Tempus combines multi-modal clinical and genomic data with AI for precision medicine, overlapping with BC Platforms on pharma R&D analytics, biomarker discovery and clinical-genomic data networks.
• Health Catalyst: Health Catalyst is a healthcare data and analytics platform serving hospital systems and life sciences; broader in scope than BC Platforms but competes for healthcare institution analytics and TRE-style budgets.
• Palantir Technologies (Foundry for Health / FedStart): Palantir Foundry underpins several large biomedical data initiatives (e.g., NIH, UK NHS federated programs) and competes with BC Platforms for enterprise health data analytics and TRE deployments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat8 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/BCPlatforms
• YouTubeyoutube.com/c/Bcplatforms
• Facebookfacebook.com/bcplatforms
• LinkedInlinkedin.com/company/bc-platforms

Compliance12 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries2 records

Funding overview

Funding rounds4 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BC Platforms